Search
for
Sort by
Research 30 of 1000+
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- Concept Paper on Health and Safety Issues in Day Care. Final Manuscript.
- Guidelines on the safety of light‐based home‐use hair removal devices from the European Society for Laser Dermatology
- Safety of testosterone use in women
- Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne
- The efficacy and safety of oral minoxidil greater than 5 mg daily in hair loss disorders
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis
- Oral minoxidil treatment for hair loss: A review of efficacy and safety
- Prace poglądowe Folate supplementation in patients with psoriasis treated with methotrexate – effect on safety and efficacy
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Safety update: psychiatric and sexual adverse effects with finasteride
- CARDIOVASCULAR SAFETY OF LOW-DOSE ORAL MINOXIDIL FOR ANDROGENETIC ALOPECIA IN PATIENTS WITH HYPERTENSION OR ARRHYTHMIAS
- Evaluation of the safety and efficacy of a fractional picosecond 1064 nm laser for post‐acne erythema in adult Chinese patients
- Efficiency and safety of autologous platelet-rich plasma
- Clinical and ultrasonographic evaluation of efficacy and safety of intralesional injection of autologous platelet-rich plasma in morphea: A comparative case series
- Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial
- Adverse events related to platelet-rich plasma therapy and future issues to be resolved
- Pharmaceutical and non-pharmaceutical treatments for migraine: a systematic review of efficacy and safety
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Hair transplantation issues in androgenetic alopecia
- Correction of the Cornrow Transplant and Other Common Problems in Surgical Hair Restoration
- Finasteride drug safety alert
- Marketing Experimental Stem Cell Therapies in the UK: Biomedical Lifestyle Products and the Promise of Regenerative Medicine in the Digital Era
- Clinical Management of Youth with Gender Dysphoria in Vancouver
- Use of metformin in pediatric age
- Safety and Efficacy of Deeply Rooted<sup>®</sup> Nutraceutical for Hair Growth in Women
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results